Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Growth suppression by glucocorticoid therapy

D B Allen1

  • 1Department of Pediatrics, University of Wisconsin School of Medicine, Madison, USA.

Endocrinology and Metabolism Clinics of North America
|September 1, 1996
PubMed
Summary

Glucocorticoids (GC) suppress growth by affecting endocrine and metabolic processes. Growth hormone (GH) therapy can counteract these effects in children, but risks require further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lack of association between gestational age adjusted TSH percentiles and neurodevelopmental outcomes among preterm infants.

Journal of neonatal-perinatal medicine·2022
Same author

Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium.

Hormone research in paediatrics·2019
Same author

GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.

European journal of endocrinology·2015
Same author

Familial and individual predictors of obesity and insulin resistance in urban Hispanic children.

Pediatric obesity·2015
Same author

Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months.

Journal of the American Academy of Dermatology·2002
Same author

Prader-Willi syndrome: how does growth hormone affect body composition and physical function?

Journal of pediatric endocrinology & metabolism : JPEM·2002

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Therapy
  • Glucocorticoid Effects

Background:

  • Glucocorticoids (GC) significantly impair growth by disrupting crucial endocrine and metabolic pathways.
  • Exogenous GC, in various forms and doses, can inhibit growth in pediatric populations.
  • These catabolic effects impact bone, nitrogen, and collagen metabolism, essential for development.

Purpose of the Study:

  • To evaluate the efficacy and safety of growth hormone (GH) therapy in counterbalancing GC-induced growth suppression.
  • To determine factors influencing GH responsiveness in children with GC-dependent conditions.
  • To assess the short-term and potential long-term risks associated with combined GH and GC therapy.

Main Methods:

  • Review of existing literature on GC effects on growth and GH counteraction.
  • Analysis of GH responsiveness based on GC dosage and disease severity.
  • Evaluation of reported short-term and potential long-term adverse events.

Main Results:

  • GC significantly inhibit growth through endocrine and metabolic interference.
  • GH therapy can partially or fully counteract GC-induced growth inhibition.
  • GH responsiveness is contingent upon GC dose and underlying disease severity.
  • Short-term risks of combined GH and GC therapy appear low.

Conclusions:

  • Combined GH and GC therapy is experimental for GC-dependent children.
  • Careful monitoring and data collection are crucial for children receiving this combined therapy.
  • Longer-term risks, including allograft function, survival, disease activity, and oncologic risks, warrant further investigation.

Related Experiment Videos